A critical advance in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant suppressor protein is frequently disabled in many kinds of cancer, resulting https://extrabookmarking.com/story21946594/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-pathway-for-tumor-therapy